Department of Anesthesiology and Operative Intensive Care Medicine Campus Virchow-Klinikum
Berlin, 13353, Germany
NCT Number: NCT04775017
The global pandemic caused by the SARS-CoV-2 virus is confronting the German health system with a novel pathogen. This means that a timely evaluation of all available results is required. In the field of intensive care in particular, there are significant gaps in knowledge, particularly with regard to delirium. In this respect, this study also serves directly to investigate the pathways of delirium outcome in COVID-19 patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Berlin, 13353, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All patients with SARS-CoV-2 positive Covid-19 disease
Exclusion criteria
Time frame: 01.01.2020 - 21.02.2022
Delirium is measured by validated screening scores.
Time frame: 01.01.2020 - 21.02.2022
Risk factors are defined according to actual literature e.g. obesity, diabetes or hypertension.
Time frame: 01.01.2020 - 21.02.2022
Patient characteristics at hospital admission e.g. score level
Time frame: 01.01.2020-31.07.2020
Monitoring of blood gas analysis
Time frame: 01.01.2020-31.07.2020
Monitoring of enteral nutrition
Time frame: 01.01.2020 - 21.02.2022
Monitoring of parenteral nutrition
Time frame: 01.01.2020 - 21.02.2022
Monitoring of serum albumin level
Time frame: 01.01.2020 - 21.02.2022
Monitoring of total protein level
Time frame: 01.01.2020 - 21.02.2022
Monitoring of phosphate levels
Time frame: 01.01.2020 - 21.02.2022
Monitoring of triglyceride levels
Time frame: 01.01.2020 - 21.02.2022
Caloric intake is measured by total daily energy supply.
Time frame: 01.01.2020 - 21.02.2022
Respiratory factors are measured respiratory setting
Time frame: 01.01.2020 - 21.02.2022
Monitoring of interleukine level
Time frame: 01.01.2020 - 21.02.2022
Monitoring of cytokine level
Time frame: 01.01.2020 - 21.02.2022
Monitoring of big immune status
Time frame: 01.01.2020 - 21.02.2022
Monitoring of t-cell population
Time frame: 01.01.2020 - 21.02.2022
Toxic-drug factors are measured by concomitant medication.
Time frame: 01.01.2020 - 21.02.2022
Sociodemographic factors are measured by Audit, Fagerström, occupation, age, gender, cognitive status.
Time frame: 01.01.2020 - 21.02.2022
Breathing hours are measured by non-invasive and invasive ventilation.
Time frame: 01.01.2020 - 21.02.2022
Length of intensive care unit stay is measured in days of stay in the intensive care unit.
Time frame: 01.01.2020 - 31.07.2022
Length of hospital stay is measured in days of stay in hospital.
Time frame: 01.01.2020 - 21.02.2022
Adverse Events defined by thromboembolic events, nosocomial infections, septic shock, acute renal failure, heart attack, post-intensive care syndrome and death are recorded until hospital discharge.
Time frame: 01.01.2020 - 21.02.2022
Post Intensive Care Unit Syndrome (PICS) is measured by a validated battery (composite endpoint).
Time frame: 01.01.2020 - 21.02.2022
Mortality is measured in the hospital
Time frame: 01.01.2020 - 31.08.2022
Mortality is measured until 180 days
Charite University, Berlin, Germany
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05027217
Agnosia, Analgesia
Oxford, United Kingdom
View Trial DetailsNCT04099472
Confusion, Critical Illness
Calgary, Alberta, Canada
View Trial DetailsNCT07496255
Intensive Care Acquired Cognitive Impairment, Intensive Care Unit Delirium
Indianapolis, Indiana, United States
View Trial DetailsNCT04957238
Aberrant Motor Behavior in Dementia, Agitation,Psychomotor
Aurillac, France
View Trial Details